Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03747367 · ClinicalTrials.gov registry record · NA
The Microbiome and Resilience to Sleep and Circadian Disruption
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03747367 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 55 participants.
The verdict
NCT03747367, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeasures for people who do not sleep enough and need to be active at different times of the day and night (e.g., emergency workers and military personnel).
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Prebiotic
- BEHAVIORAL Insufficient Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-10-21 |
| Est. Completion | 2020-03-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03747367
The ClinicalTrials.gov registry entry for NCT03747367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03747367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03747367 about?
NCT03747367 is a clinical study titled "The Microbiome and Resilience to Sleep and Circadian Disruption". This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeas...
What is the current status of trial NCT03747367?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-10-21. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT03747367?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Prebiotic (DIETARY_SUPPLEMENT), Insufficient Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT03747367?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.